Stock Events

Stock Events

Merck 

CL$123,900.00
9512
+CL$0.00+0%Tuesday 13:36

Statistics

Day High
123,900
Day Low
123,900
52W High
146,390
52W Low
76,219
Volume
10
Avg. Volume
0
Mkt Cap
305.68T
P/E Ratio
-
Dividend Yield
2.68%
Dividend
3,321.12

Upcoming

Dividends

2.68%Dividend Yield
Oct 2026
CL$830.28
Jul 2026
CL$794.46
Apr 2026
CL$778.99
Jan 2026
CL$762.02
Oct 2025
CL$776.88
10Y Growth
9.73%
5Y Growth
10.29%
3Y Growth
8.85%
1Y Growth
0.38%

Earnings

Feb 2Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
-1,327.15
-64.83
1,197.48
2,459.8
Expected EPS
1,734.98858571
Actual EPS
N/A

Financials

28.22%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
60.69TRevenue
17.13TNet Income

Analyst Ratings

$86,294.61Average Price Target
The highest estimate is ⁦95,794.20⁩.
From 20 ratings within the last 6 months. This is not an investment recommendation.
Buy
80%
Hold
20%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MRKCL.SN. It's not an investment recommendation.
Microsoft
2197
MSFT
Realty Income
2133
O
Apple
1871
AAPL
Abbvie
1856
ABBV

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer competes directly with Merck in various therapeutic areas, including vaccines and oncology.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its pharmaceutical segment, competes in areas such as immunology and cancer treatments.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline competes with Merck in the vaccines market and respiratory diseases.
Novartis
NVS
Mkt Cap303.67B
Novartis competes in multiple areas including oncology, neuroscience, and cardiovascular health.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes with Merck in areas such as immunology and oncology, particularly with its Humira product.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb competes in the oncology space, directly challenging Merck's Keytruda with its Opdivo.
Lilly(Eli) &
LLY
Mkt Cap1.26T
Eli Lilly competes in the diabetes and cancer treatment markets, areas of focus for Merck.
AMGEN
AMGN
Mkt Cap251.94B
Amgen competes with Merck in areas such as oncology and cardiovascular diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche, through its Genentech subsidiary, competes in oncology, including direct competition in the PD-L1 inhibitor space.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes with Merck in the diabetes, cardiovascular, and vaccines markets.

About

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Show More
CEO
Robert Davis
Employees
75000
Country
United States
ISIN
US58933Y1055
WKN
000A0YD8Q

Listings

NEO
CA
MRK.NEO
BOATS
BOATS
MRK.BOATS
F
DE
6MK0.F
SN
CL
MRK.SN

0 Comments

Share your thoughts

FAQs

What is Merck stock price today?▼
The current price of MRKCL.SN is CL$123,900.00 CLP — it has increased by +0% in the past 24 hours. Watch Merck stock price performance more closely on the chart.
What is Merck stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Chilean Stock Exchange exchange Merck stocks are traded under the ticker MRKCL.SN.
What is Merck market cap?▼
Today Merck has the market capitalization of 305.68T
When is the next Merck earnings date?▼
Merck is going to release the next earnings report on February 2, 2027.
What were Merck earnings last quarter?▼
MRKCL.SN earnings for the last quarter are 2,459.8 CLP per share, whereas the estimation was 2,060.12 CLP resulting in a +19.4% surprise. The estimated earnings for the next quarter are N/A CLP per share.
What is Merck revenue for the last year?▼
Merck revenue for the last year amounts to 60.69T CLP.
What is Merck net income for the last year?▼
MRKCL.SN net income for the last year is 17.13T CLP.
Does Merck pay dividends?▼
Yes, MRKCL.SN dividends are paid quarterly. The last dividend per share was 830.28 . As of today, Dividend Yield (FWD)% is 2.68%.
How many employees does Merck have?▼
As of November 4, 2026, the company has 75,000 employees.
In which sector is Merck located?▼
Merck operates in the Health & Wellness sector.
When did Merck complete a stock split?▼
Merck has not had any recent stock splits.
Where is Merck headquartered?▼
Merck is headquartered in RAHWAY, United States.